[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-kidney-disease-stage-4b\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-kidney-disease-stage-4b":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100579510",false,"NCT06825234","Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B\u002F5","PROFILER","Inclusion Criteria:\n\n* Patients with CKD stage 4B or 5 (first consultation with GFR \\\u003C 20 mL\u002Fmin \u002F1.73 m2 in CKD-EPI 2009).\n* Fluency in French\n* Membership of a French social security scheme\n* Non-opposition from the subject to participate in the study\n\nExclusion Criteria:\n\n* Subjects with limited legal capacity.\n* Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.\n* Subjects with no social security coverage.\n* Subjects judged by the investigator to be unlikely to comply with study procedures\n* Subjects unable to understand the reasons for the study; psychiatric disorders judged by the investigator to be incompatible with inclusion in the study.","ALL","75 Years",{"count":18,"type":19},390,"ESTIMATED","OBSERVATIONAL","The aim of this study is to determine a multidimensional signature (integrating frailty and patient-reported outcomes measures (PROMs) at entry into stage 4B\u002F5 CKD) to improve prediction of renal death (dialysis, transplantation, conservative management, death).",[23,24],"Chronic Kidney Disease Stage 5","Chronic Kidney Disease Stage 4B",[26,27,28],"Frailty","Patient-Related Outcomes","Personalised care","NOT_YET_RECRUITING","2025-04-30",{"date":32,"type":33},"2025-05-01","ACTUAL",{"date":35,"type":19},"2025-06",{"date":37,"type":19},"2028-12",{"name":39,"class":40},"Centre Hospitalier Universitaire de Besancon","OTHER",2,""]